{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 6, "transaction_limit": 160, "filters": {"q": "", "ticker": "IKT", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 6, "acquisition_count": 6, "disposal_count": 0, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "positive", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 6, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-26", "acquisitions": 6, "disposals": 0, "total": 6, "bar_width": 100.0}], "side_mix": {"acquisitions": 6, "disposals": 0, "acquisition_share": 100.0, "disposal_share": 0.0}}, "company_flows": [{"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-26", "acquisitions": 6, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}], "company_overview": [{"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-26", "filings": 6, "acquisitions": 6, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}], "transactions": [{"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "AURENTZ, VINCENT", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.537054+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}, {"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "BELLINI, ROBERTO", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.539047+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}, {"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "BERMAN, DENNIS N", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.541028+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}, {"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "CANNER, DAVID", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.529086+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}, {"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "KUSH, ARVIND", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.532982+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}, {"symbol": "IKT", "name": "Inhibikase Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "MUNSHI, AMIT", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 155000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:09:42.535218+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ikt/", "research_links": {"chart": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/", "report": "/terminal/c530580c-cf29-4580-a1ff-a5cc54bf23e7/report/", "factor": "/factors/ticker/c530580c-cf29-4580-a1ff-a5cc54bf23e7/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}